Beam Therapeutics Overview
Beam Therapeutics Target Price
Analysts' 12-month price predictions for BEAM.
Share Price
$20.88
Average Target Price
$55.00
163.4% upside
163.4% upside1 analysts in the last 4 months
High: $55 | Low: $55
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-07 | GuggenheimDebjit Chattopadhyay | $55 | 163.4% upside |  |
| 2025-03-03 | Scotiabank | $25 | 19.7% upside | |
| 2025-01-07 | Tudor PickeringWilliam Pickering | $37 | 77.2% upside | |
| 2024-11-06 | Leerink PartnersRick Bienkowski | $39 | 86.8% upside | |
| 2024-11-05 | BMO CapitalKostas Biliouris | $57 | 173% upside | |
| 2024-09-11 | Stifel NicolausBenjamin Burnett | $69 | 230.5% upside | |
| 2023-02-01 | Cantor Fitzgerald | $62 | 196.9% upside | |
| 2022-12-20 | BMO CapitalKostas Biliouris | $66 | 216.1% upside | |
| 2022-12-13 | Citigroup | $62 | 196.9% upside | |
| 2022-04-28 | Credit Suisse | $62 | 196.9% upside | |